Zenas BioPharma, Inc.'s obexelimab's potential in treating autoimmune diseases and upcoming phase 2 & 3 trial results. Read ...
China: A recent study highlights the potential of ultrasonic viscoelastic imaging as a noninvasive tool for evaluating ...
The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...
Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...
Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote "FOR" the merger Transaction expected to be comple ...
Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote "FOR" the merger Transaction expected to be comple ...
The Switzerland-based firm's MosaiQ AiPlex Connective Tissue Diseases (CTDplus) assay is used to aid the diagnosis of autoimmune diseases.
AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the ...
Frequent, graphic nightmares aren't just unsettling—they can be your brain’s way of sounding the alarm. In some cases, ...
Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...
A risk prediction score that uses machine learning and a patient’s genetic information may identify autoimmune conditions up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback